Shire, manufacturer of immune globulin for the treatment of primary immunodeficiency (PI), has launched a social campaign, #PIPostsThanks, to spotlight the unsung heroes who make a difference in the lives of people living with PI. The #PIPostsThanks campaign kicked off April 22 through 29 during the seventh World PI Week to bring the PI community together to share personal journeys and highlight the efforts of those who help ease the burden of living with PI. “As a leader in developing innovative treatments and support services for PI patients, Shire values the opportunity to serve this community,” said Kasha Witkos, global head of immunology at Shire. “Through awareness campaigns such as #PIPostsThanks, we hope to raise awareness of this devastating disorder and offer our own thanks and ongoing commitment to innovating on behalf of PI patients around the world. We are determined to make a meaningful difference for patients with PI.”

Throughout World PI Week, Shire is welcoming supporters from around the world to share thank you notes, videos, photos and more using the #PIPostsThanks hashtag. Shire is giving its thanks to the PI community through MyIgSource (U.S. audiences) and Rare2Aware (out-of-the-U.S. audiences) social channels in continuing to drive dialogue with patients around the globe.